CD86 and systemic lupus erythematosus: The results revealed that the activation marker CD86 was significantly upregulated in active SLE B cells compared with healthy donors (4.8±0.4% versus 7.8±1.0% Figure 1a), whereas the expression of CD40 and CD80 was unchanged (Figures 1b and c).